Insight I Sino Bioengineering

Virus-like particles (VLPs) are nanoscale multimers self-assembled from viral structural proteins. Devoid of viral genomes and thus non-infectious, they hold tremendous potential in ……

As one of the most widely adopted nanomedicine delivery systems to date, liposomes, first discovered in the 1960s, have been extensively deployed in anti-tumor therapeutics, nucleic ……

The pharmaceutical industry stands apart from other industrial sectors for one critical reason: every project decision must align with core manufacturing principles and stringent reg……

With the rapid expansion of the global pharmaceutical and healthcare industry and increasingly stringent requirements for product quality, the cleanliness of production environments……

Sterile pharmaceutical manufacturing represents one of the most stringently regulated and technically sophisticated sectors in the pharmaceutical industry. Its core ob……

Driven by the rapid advancement of synthetic biology in recent years, a growing number of enterprises have transitioned from lab-scale R&D to industrial manufacturing. Neverthel……

A quiet transformation is unfolding within aseptic pharmaceutical production, particularly vaccine manufacturing. Traditional facilities relied on an intricate “steel ecosyste……

In recent years, the growing prevalence of subcutaneous injectable formulations and high-concentration drug substance (DS) materials has brought protein discoloration to the forefro……

Virus-like particles (VLPs) are nanoscale multimers self-assembled from viral structural proteins. Devoid of viral genomes and non-infectious, they hold tremendous potential across ……

Biosimilar facility development continues to confront a prevalent and critical industry challenge: delivering fully cGMP-compliant, high-throughput biomanufacturing infrastructure un……

At the cutting edge of biomedicine, liposomes have emerged as star delivery vehicles in the pharmaceutical industry, owing to their unique biomimetic architecture and superior drug ……

Regulatory approval has long stood as one of the most challenging, high-stakes and unpredictable bottlenecks in the entire development lifecycle of new pharmaceutical, biotech and li……

The pharmaceutical industry is defined by rigorous regulatory requirements, intense time-to-market pressure, and zero-tolerance standards for facility quality and compliance. For fas……

The pharmaceutical industry differs from other industrial sectors in its strict adherence to process rationality and regulatory compliance. While conventional engineering prioritizes……

In downstream biopharmaceutical processes, depth filtration features high dirt-holding capacity and multi-mechanism retention (mechanical interception/size exclusion, electrostatic ……

In recent years, mRNA technology has emerged as a transformative breakthrough in the biopharmaceutical industry. Characterized by rapid research and development cycles, flexible pro……